Home / Blogs / Blog Details

A Brief Overview of C-Reactive protein Test (CRP)



C-reactive proteins are blood markers that appear as an indication for inflammation in the body. It is generally found in the liver and the amount of C-reactive proteins present in the blood can be measured by assessing blood. Erythrocyte sedimentation rate (ESR) and blood platelet count have the capability of increasing in amount by any sort of reaction and c-reactive proteins are such acute phase reactants as well that will increase in number if high inflammatory conditions are acquired. The test of C-reactive proteins has proven to be much beneficiary in comparisons with cholesterol tests to estimate coronary conditions in women. Less C-reactive protein content implies that there are very less burns or inflammations in the body and hence the assurance of a robust condition.
Market value of C-Reactive protein Test (CRP):

The global market value and size of C-reactive protein test sector has tremendously soared high over the past few years and has yielded profit in huge quantity. The Cumulative Average Growth Rate (CAGR) percent will reportedly reach the set target in a few years. The growth rate in various disease conditions also determines the average growth rate of the whole C - reactive protein test industry. The need for c-reactive proteins tests have increased with increased prevalence of conditions like burns, trauma, infections like pneumonia and tuberculosis, cardio vascular arrests, chronic inflammatory diseases like lupus, vacuities , or rheumatoid arthritis, inflammatory bowel disease and certain forms of cancers. There are numerous studies divulging that the presence of high c-reactive proteins in men would possibly be an indicator for heart disease or stroke. Hence, the vitality offered for C-reactive protein tests by medical practitioners has increased manifold. The crucial competitors in the market areSiemens healthcare diagnostics, Roche diagnostics gmbh, Randox laboratories, Abbott, Arlington scientific, Beckman coulter, Horiba abx sas, Audit, Ortho clinical diagnostics(j&j),Ningbo c-reactive protein test(crp)system, Spinreact, Leadman biochemistry, Prodia diagnostics, Getein biotech, Boditech, Fujifilm corporation, Wako pure chemical, Beijing strong biotechnologies, Kanto chemical, Biosino, Kehua group, and Wondfo.

Market trend:

Although C-reactive protein tests encompass very low levels of risk for individuals who undertake blood drawing procedures, there are slight possibilities for the events of excessive bleeding, dizziness or light headedness and bruising or infection at the puncture site. This could be a possible restraint for the growth of hype; however, it is common for almost all blood drawing procedures to have these possible side effects. The requirement to assess heart diseases and stroke conditions has considerably outweighed these less potential complications. 


The global market size of C-reactive protein test (CRP) sector would significantly grow and could possibly furnish highly remunerated profit rate in the impending years.